NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.

In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...

Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four ...

A research team from McGill University has developed a diagnostic system that can identify bacteria, but also determine the antibiotics likely to neutralize them, all in just 36 minutes. This is ...

Valley Diagnostics secured exclusive global rights to patented biomarkers for prostate cancer, lung cancer, bovine ...

The COVID-19 pandemic marked the first time in the history of pandemics where self-testing was used as an essential component of a widespread public infection control and prevention strategy. Nearly ...

Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new ...

The U.S. Food and Drug Administration allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens (proteins) in human blood from certain living individuals and samples from ...

Globally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before they are diagnosed. A new rapid test could save lives by diagnosing patients in ...